Digest Network Come funziona
Network
/
Società
Ho
Non verificato

Hologic, Inc.

Di cosa scriviamo

Attrezzature medico-sanitarieOncologiaSaluteSanitàVetrine/Shopping

55 comunicati stampa

Guarda tutti i comunicati
20/04/2026
New Evidence Backs Hologic’s AI-Powered Mammography Technology for Detecting Challenging Cancers
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
07/04/2026
Mercato del lavoro
Mercato azionario
Salute
Vetrine/Shopping
Sanità
Medicina nucleare
Blackstone and TPG Complete Acquisition of Hologic
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
06/04/2026
Mercato del lavoro
Sanità
Salute
Attrezzature medico-sanitarie
Hologic Chief Executive Officer Steve MacMillan to Retire Upon Close of Go-Private Transaction
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
17/03/2026
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
04/02/2026
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
29/01/2026
Comunicazione
Attrezzature medico-sanitarie
Salute
Sanità
Web e Social Network
Telefonia e Varie
Mercato azionario
Hologic Announces Financial Results for First Quarter of Fiscal 2026
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
16/01/2026
Oncologia
Salute
Vetrine/Shopping
Sanità
Medicina nucleare
Mercato azionario
Finanza
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
13/01/2026
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
16/12/2025
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0
02/12/2025
Biotecnologia
Medicina - Varie
Sanità
Salute
Vetrine/Shopping
Oncologia
Eventi
Industria
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy Duration
Fonte
Hologic, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0